1.275
Cibus Inc stock is traded at $1.275, with a volume of 36,400.
It is up +0.39% in the last 24 hours and down -2.67% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.27
Open:
$1.28
24h Volume:
36,400
Relative Volume:
0.07
Market Cap:
$97.32M
Revenue:
$4.29M
Net Income/Loss:
$-104.03M
P/E Ratio:
-0.6477
EPS:
-1.9685
Net Cash Flow:
$-50.65M
1W Performance:
+3.66%
1M Performance:
-2.67%
6M Performance:
-18.27%
1Y Performance:
-19.30%
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CBUS
Cibus Inc
|
1.275 | 96.94M | 4.29M | -104.03M | -50.65M | -1.9685 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.73 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
611.46 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
878.90 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.34 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
155.46 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus names board member Craig Wichner as new CEO - MSN
Cibus (CBUS) CEO receives 894K RSUs and 1.05M stock options grant - Stock Titan
Cibus, Inc. Appoints Craig Wichner as CEO to Lead Next Phase of Growth and Innovation in Agricultural Biotechnology - Minichart
Cibus Resets Leadership and Board to Drive Commercialization - TipRanks
Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO - Stock Titan
Cibus Names Board Member Craig Wichner as CEO - Moomoo
Cibus appoints Craig Wichner as chief executive officer By Investing.com - Investing.com Australia
Cibus (CBUS) Announces Leadership Changes - GuruFocus
Cibus Appoints New CEO to Drive Commercialization - Intellectia AI
Cibus appoints Craig Wichner as chief executive officer - Investing.com
Cibus, Inc. Announces Leadership Transition with Appointment of Craig Wichner as CEO - Quiver Quantitative
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation - lincolnjournal.com
Cibus Q1 earnings call highlights - MSN
Cibus, Inc. 2026 Annual Meeting Results: Director Elections, Executive Compensation Approval, and Auditor Ratification (Form 8-K) – Minichart - Minichart
Cibus Stockholders Approve Directors and Governance Measures - TipRanks
Cibus (CBUS) 2026 meeting backs board slate, executive pay and BDO - Stock Titan
Cibus (CBUS) director receives grant of 77,586 stock options - Stock Titan
Cibus (CBUS) director Moretti granted 77,586 options at $1.39 strike - Stock Titan
Stock option grant for Cibus (CBUS) director Rory B. Riggs - Stock Titan
Cibus (CBUS) director Gerhard Prante awarded 64,748 RSUs in equity grant - Stock Titan
Cibus (NASDAQ: CBUS) director awarded 64,748 RSUs in new stock grant - Stock Titan
Cibus (CBUS) director Kimberly Ann Box receives 77,586 stock options at $1.39 strike - Stock Titan
Cibus (CBUS) director Craig Wichner granted 77,586 stock options at $1.39 strike - Stock Titan
Director Urban Thomas awarded 64,748 Cibus (CBUS) shares in Form 4 filing - Stock Titan
Cibus (CBUS) upgraded to buy: What does it mean for the stock? - MSN
CBUS News | CIBUS INC (NASDAQ:CBUS) - ChartMill
Cibus outlines runway into late Q1 2027 while shifting US rice launch to 2029 - MSN
Cibus Global LLC (NASDAQ: CBUS) Share Price, CBUS Stock News, CBUS Share Price & Updates - Kalkine
Cibus Inc. Q1 2026 Earnings: Narrowed Loss Surprises Estimates Amid Pre-Revenue ProgressEarnings Trend Analysis - The Legal Advocate
[EFFECT] Cibus, Inc. SEC Filing - Stock Titan
Cibus Inc. Q1 2026 Earnings: Narrowing Losses Amid Pre-Revenue PhaseAdjusted Earnings Analysis - The Legal Advocate
Cibus Inc. (CBUS) Holds Steady at $1.38 as Consolidation Continues Near Support LevelsStock Buy Zone - The Legal Advocate
Cibus (CBUS) registers 10.74M shares issuable on warrants — issuer to receive proceeds - Stock Titan
Cibus (NASDAQ: CBUS) files at‑the‑market $50M shelf with Jefferies - Stock Titan
Cibus Inc. (CBUS) Faces Selling Pressure as Shares Test Key Support ZoneOBV Breakout - The Legal Advocate
CBUS SEC FilingsCIBUS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Cibus, Inc. (NASDAQ:CBUS) Q1 2026 Earnings Call Transcript - Insider Monkey
Cibus Earnings Call: Cash Extended, Execution Critical - TipRanks
CBUS Technical Analysis | Trend, Signals & Chart Patterns | CIBUS INC (NASDAQ:CBUS) - ChartMill
MSN Money - MSN
Number of shareholders of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus (CBUS) Q1 2026 Earnings: EPS -$0.33, Revenue $1.681M -- Bo - GuruFocus
Cibus Inc to offer securities with aggregate initial offering price up to $200 millionSEC filing - marketscreener.com
Cibus IncTo Offer Securities With Aggregate Initial Offering Price Up To $200 MillionSEC Filing - TradingView
Cibus (CBUS) registers $200M shelf and $50M ATM via Jefferies - Stock Titan
Q1 2026 Cibus Inc Earnings Call Transcript - GuruFocus
Cibus, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):